Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Core Laboratories N.V. (CLB)

Core Laboratories N.V. (CLB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,272,987
  • Shares Outstanding, K 46,240
  • Annual Sales, $ 487,270 K
  • Annual Income, $ -97,640 K
  • 60-Month Beta 3.38
  • Price/Sales 2.61
  • Price/Cash Flow 21.78
  • Price/Book 16.69
Trade CLB with:

Options Overview

Details
  • Implied Volatility 61.01%
  • Historical Volatility 54.51%
  • IV Percentile 5%
  • IV Rank 7.37%
  • IV High 122.66% on 04/21/20
  • IV Low 56.10% on 03/22/21
  • Put/Call Vol Ratio 0.73
  • Today's Volume 38
  • Volume Avg (30-Day) 188
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 4,233
  • Open Int (30-Day) 1,906

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.13
  • Number of Estimates 6
  • High Estimate 0.15
  • Low Estimate 0.11
  • Prior Year 0.31
  • Growth Rate Est. (year over year) -58.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.20 +5.08%
on 04/13/21
34.91 -21.14%
on 03/18/21
-6.97 (-20.20%)
since 03/16/21
3-Month
26.20 +5.08%
on 04/13/21
41.99 -34.43%
on 03/11/21
-6.22 (-18.43%)
since 01/15/21
52-Week
10.97 +151.07%
on 04/20/20
41.99 -34.43%
on 03/11/21
+16.72 (+154.67%)
since 04/16/20

Most Recent Stories

More News
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CLB : 27.53 (unch)
CLC Nearly Triples its Cannabis Extraction Capacity with the Industry's First Installation of Vitalis' Cosolvent Injection System Add-On

Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that it has completed an eight-week controlled testing...

CLC.CN : 0.550 (+1.85%)
CLCFF : 0.4431 (+3.89%)
CLB : 27.53 (unch)
Salvatore Milia Appointed to CLC Board of Directors, Assigned to Lead R&D Efforts for Production of TAAT(TM)

Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE:CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that Salvatore Milia has been appointed to the Company's...

CLC.CN : 0.550 (+1.85%)
CLCFF : 0.4431 (+3.89%)
CLB : 27.53 (unch)
TAAT.CN : 3.130 (+5.03%)
Core Laboratories' First Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 22, 2021

, /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2021 conference call over the Internet at / on , 2021. 

CLB : 27.53 (unch)
To Lead Commercialization Efforts, Renowned Agriculture Commodities Trader Rob Jones is Named President of Christina Lake Cannabis

With 35 years of experience in trading agriculture commodities globally, CLC's Executive VP of Business Development and Sales Rob Jones has been named President of the Company. Having played a significant...

CLC.CN : 0.550 (+1.85%)
CLCFF : 0.4431 (+3.89%)
CLB : 27.53 (unch)
Christina Lake Cannabis to Become Exclusive Developer and Distributor of TAAT(TM) and Beyond Tobacco(TM) in Canada

Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE:CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) is pleased to announce that it has entered into a memorandum of understanding...

CLC.CN : 0.550 (+1.85%)
CLCFF : 0.4431 (+3.89%)
CLB : 27.53 (unch)
TAAT.CN : 3.130 (+5.03%)
Christina Lake Cannabis Announces Uplisting to OTCQB(R) Market in the United States

Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE: CLC) (FRANKFURT: CLB) (OTC: CLCFF) is pleased to announce that it has received approval from OTC Markets Group...

OTCM : 40.0000 (-0.62%)
CLC.CN : 0.550 (+1.85%)
CLB : 27.53 (unch)
CLCFF : 0.4431 (+3.89%)
"From Seed to Sale": Fully Integrated Production Chain can Provide Unique Advantages to Christina Lake Cannabis in Commercializing Distillate Oils

Christina Lake Cannabis Corp. (the "Company" or "CLC" or "Christina Lake Cannabis") (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that one of its cannabis distillate oils has been certified to have...

CLC.CN : 0.550 (+1.85%)
CLB : 27.53 (unch)
Core Labs' (CLB) Q4 Earnings and Revenues Beat Estimates

In the December quarter, Core Labs (CLB) generates $57.9 million in operating cash and its capital expenditure totals $11.9 million, leading to a $46-million free cash flow (FCF) recognition.

SLB : 26.29 (-1.39%)
HAL : 20.69 (-1.85%)
CLB : 27.53 (unch)
KLXE : 8.70 (-16.35%)
Core Laboratories (CLB) Q4 Earnings and Revenues Top Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 5.88% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

CLB : 27.53 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Core Laboratories N.V. is a leading provider of proprietary and patented Reservoir Description and Production Enhancement services. Core Laboratories' reservoir optimization technologies are used to increase total recovery from existing fields. Core Laboratories' services enable clients to optimize reservoir...

See More

Key Turning Points

3rd Resistance Point 29.68
2nd Resistance Point 28.93
1st Resistance Point 28.23
Last Price 27.53
1st Support Level 26.78
2nd Support Level 26.03
3rd Support Level 25.33

See More

52-Week High 41.99
Fibonacci 61.8% 30.14
Last Price 27.53
Fibonacci 50% 26.48
Fibonacci 38.2% 22.81
52-Week Low 10.97

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar